EQL Pharma AB (publ) (STO:EQL)
Sweden flag Sweden · Delayed Price · Currency is SEK
80.70
-1.20 (-1.47%)
At close: Jun 5, 2025

EQL Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Market Capitalization
2,3452,0641,2291,087974994
Upgrade
Market Cap Growth
67.85%67.85%13.10%11.64%-2.05%153.33%
Upgrade
Enterprise Value
2,7152,2051,3171,0751,010980
Upgrade
Last Close Price
80.7071.0042.3037.4033.5034.20
Upgrade
PE Ratio
56.0447.8554.1535.1530.8695.88
Upgrade
PS Ratio
6.285.534.654.182.385.55
Upgrade
PB Ratio
10.619.346.927.027.8810.90
Upgrade
P/TBV Ratio
--278.3320.8238.62-
Upgrade
P/FCF Ratio
---40.0223.6316.67
Upgrade
P/OCF Ratio
---39.3623.2816.55
Upgrade
EV/Sales Ratio
7.275.904.994.142.475.47
Upgrade
EV/EBITDA Ratio
34.7428.2232.9422.7024.9259.15
Upgrade
EV/EBIT Ratio
40.2932.7340.3826.0126.0185.05
Upgrade
EV/FCF Ratio
-88.20--39.5924.5216.43
Upgrade
Debt / Equity Ratio
2.042.040.680.430.620.96
Upgrade
Debt / EBITDA Ratio
5.785.783.001.371.835.26
Upgrade
Debt / FCF Ratio
---2.451.851.46
Upgrade
Asset Turnover
0.630.630.800.991.861.09
Upgrade
Inventory Turnover
1.531.531.742.697.473.62
Upgrade
Quick Ratio
1.001.000.570.830.770.56
Upgrade
Current Ratio
1.811.811.221.431.251.03
Upgrade
Return on Equity (ROE)
21.63%21.63%13.66%22.21%29.37%12.04%
Upgrade
Return on Assets (ROA)
7.12%7.12%6.18%9.87%11.00%4.39%
Upgrade
Return on Capital (ROIC)
8.68%8.68%7.85%12.27%12.84%5.03%
Upgrade
Return on Capital Employed (ROCE)
11.50%11.50%15.40%24.50%27.90%10.60%
Upgrade
Earnings Yield
1.84%2.09%1.85%2.84%3.24%1.04%
Upgrade
FCF Yield
-1.31%-1.49%-1.01%2.50%4.23%6.00%
Upgrade
Buyback Yield / Dilution
-2.86%-2.86%1.57%-1.59%-3.37%
Upgrade
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.